Liquid Chromatography–Mass Spectrometry-Based Nontargeted Metabolomics Predicts Prognosis of Hepatocellular Carcinoma after Curative Resection-Reference-Cited by-同舟云学术

Liquid Chromatography–Mass Spectrometry-Based Nontargeted Metabolomics Predicts Prognosis of Hepatocellular Carcinoma after Curative Resection

Published:2020-07-03 Issue:8 Volume:19 Page:3533-3541
ISSN:1535-3893
Container-title:Journal of Proteome Research
language:en
Short-container-title:J. Proteome Res.

Author:

Wang Qingqing¹²^ORCID,Su Benzhe³,Dong Liwei⁴,Jiang Tianyi⁴,Tan Yexiong⁴,Lu Xin¹,Liu Xinyu¹^ORCID,Lin Xiaohui³,Xu Guowang¹^ORCID

Affiliation:

1. CAS Key Laboratory of Separation Science for Analytical Chemistry, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian 116023, China

2. University of Chinese Academy of Sciences, Beijing 100049, China

3. School of Computer Science & Technology, Dalian University of Technology, Dalian 116024, China

4. International Cooperation Laboratory on Signal Transduction, Eastern Hepatobiliary Surgery Institute, The Second Military Medical University, Shanghai 200438, China

Funder

Ministry of Science and Technology of the People's Republic of China

National Natural Science Foundation of China

Publisher

American Chemical Society (ACS)

Subject

General Chemistry,Biochemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jproteome.0c00344

Reference35 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. A Large‐scale, multicenter serum metabolite biomarker identification study for the early detection of hepatocellular carcinoma